SUMMARY OF THE ROLE 

You will lead in vivo study strategy, study leadership, and vendor/CRO governance to enable data-driven progression of programs from discovery toward translation, with priority focus on (1) cell therapy, followed by (2) immuno-oncology and (3) immunology. This role is primarily accountable for high-quality externalized study delivery (including NHP where appropriate), while maintaining hands-on capability for flow cytometry-based immune monitoring and critical sample processing/interpretation to ensure scientific rigor, data integrity, and rapid troubleshooting. 

ROLES & RESPONSIBILITIES 

In vivo strategy and decision science (priority: cell therapy): Define fit-for-purpose in vivo plans to characterize cell therapy activity, expansion/engraftment, persistence, trafficking/biodistribution, and pharmacodynamics, translating program hypotheses into clear endpoints, sampling schedules, and pre-defined decision criteria. Ensure study ...